The biotech’s efforts to bring its vaccines to the country mean navigating political pushback in the U.S. and the risk of ...
The number of layoffs in the U.S. pharmaceutical industry exceeded 14,000 last year, a 9% increase from 2023 ...
Moderna's bird flu vaccine development, supported by a U.S. government grant, could be a game changer if the bird flu spreads ...
Here are some of the major companies whose stocks moved on the week’s news.
The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.
With COVID vaccine sales in the doldrums and a respiratory syncytial virus (RSV) vaccine market in “contraction”, Moderna CEO ...
Shares of Moderna Inc. MRNA slid 2.13% to $42.25 Friday, on what proved to be an all-around rough trading session for the ...
Moderna/Merck partnership and its potential in personalised cancer therapies are good opportunities for long-term investors.
Moderna surged as investors turned eyed potential demand for a vaccine to protect against bird flu after the US reported its ...
In absolute dollar amount, the Cambridge drugmaker had the biggest drop in market cap among any public Massachusetts company ...